Results 121 to 130 of about 10,413 (157)
Some of the next articles are maybe not open access.

Medicinal applications of cannabis/cannabinoids

Current Opinion in Psychology, 2021
Regulatory approvals for Epidiolex (purified cannabidiol) in the treatment of childhood drug resistant epilepsy have set a precedent for the use of cannabinoids as a prescribed medicine. Two common reasons cited for the use and prescription of cannabis-based products are pain and insomnia.
Irene Braithwaite   +5 more
openaire   +2 more sources

Pharmacists and the future of cannabis medicine

Journal of the American Pharmacists Association, 2020
To summarize the history and evolution of cannabis use and policies and to review current therapeutic uses, safety, and the central role pharmacists can play.Cannabis regulation and use have evolved over the centuries and are becoming more widely accepted, with over two-thirds of states in the United States having an approved cannabis program. However,
Natalie, Schmitz, Lucas, Richert
openaire   +2 more sources

Medicinal Cannabis in Orthopaedic Practice

Journal of the American Academy of Orthopaedic Surgeons, 2020
Cannabis has gained widespread public advocacy since its legalization in several states with recent evidence suggesting that its self-reported use has increased in patients undergoing a primary total joint arthroplasty. The endocannabinoid system has been proposed to play a role in decreasing the inflammatory cascade and enhancing pain management.
Lindsay T. Kleeman-Forsthuber   +2 more
openaire   +2 more sources

Medicinal cannabis in Australia, 2016: the Cannabis as Medicine Survey (CAMS‐16)

Medical Journal of Australia, 2018
To explore patterns of cannabis use for medical purposes in Australia immediately prior to the 2016 legislation for frameworks for medical cannabis use. Design, setting: Anonymous online survey with convenience sample, April-October 2016. Participants were recruited through online media and at professional and consumer forums.Adults (at least 18 years ...
Nicholas, Lintzeris   +5 more
openaire   +2 more sources

Rescheduling Cannabis—Medicine or Politics?

JAMA Psychiatry
ImportanceIn 2023, the US Department of Health and Human Services (HHS) issued a letter to the administrator of the Drug Enforcement Administration (DEA) recommending rescheduling of cannabis (marijuana) from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Bertha K, Madras, Paul J, Larkin
openaire   +2 more sources

Cannabis in Palliative Medicine

2020
Palliative care is a specialized medical care that focuses on quality of life for patients with serious illnesses. In the realm of palliative care and symptom management, there is growing interest in the role for cannabis-based medicine. There is some evidence to support the use of cannabinoids for the palliation of some symptoms and quality of life ...
Fabienne Saint-Preux   +4 more
openaire   +1 more source

[Medicinal cannabis].

Journal de pharmacie de Belgique, 2006
Pharmaceutical grade cannabis is available to Dutch patients from public pharmacies in the Netherlands. The first part of this paper reviews the pharmaceutical and pharmacological properties of medicinal cannabis. Detailed information about its composition and quality, potential applications, methods of administration, adverse reactions, drug ...
H, Van der Meersch   +2 more
openaire   +1 more source

[Position paper on medical cannabis and cannabis-based medicines in pain medicine].

Schmerz (Berlin, Germany), 2019
Since March 2017, the prescription of medical cannabis at the expense of the statutory health insurance is possible after approval by the respective medical services. Chronic pain is the most common indication, as health claims data and the accompanying survey show.
Frank, Petzke   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy